- Exchange: NASDAQ GM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Egalet Corp+ Add to Watchlist
EGLT:US6.0800 USD 0.3500 6.11%
As of 20:10:00 ET on 10/22/2014.
Company Profile for Egalet Corp (EGLT)
Egalet Corporation is a specialty pharmaceutical company. The Company develops and markets oral products for the treatment of pain and in other indications.
Key Executives for Egalet Corp (EGLT)
|Robert S Radie "Bob"President/CEO||Stanley J Musial "Stan"CFO/Secretary|
|Mark StrobeckChief Business Officer||Jeffrey M Dayno "Jeff"Chief Medical Officer|
|Karsten LindhardtVP:Research & Development|